Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -17.60
- Piotroski Score 3.00
- Grade N/A
- Symbol (PLUR)
- Company Pluri Inc.
- Price $4.90
- Changes Percentage (1.03%)
- Change $0.05
- Day Low $4.78
- Day High $4.90
- Year High $8.48
Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II clinical trails for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18 for incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as a solution for the treatment of acute radiation syndrome. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/10/2025
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$4.12
- Trailing P/E Ratio -1.41
- Forward P/E Ratio -1.41
- P/E Growth -1.41
- Net Income $-20,888,000
Income Statement
Quarterly
Annual
Latest News of PLUR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Gold Rush's Parker Schnabel Reveals What He 'Splurges' on with His Mining Millions (Exclusive)
At just 30 years old, Gold Rush star Parker Schnabel values experiences over possessions, splurging on trips with loved ones rather than material items. His success stems from a strong work ethic inst...
By PEOPLE.com | 1 day ago -
Big Tech's AI splurge worries investors about returns
By Anna Tong, Aditya Soni and Deborah Mary Sophia(Reuters) -Big technology companies including Microsoft, Meta and Amazon are stepping up spending to build out AI data centers in a rush to meet vast d...
By Reuters | 3 weeks ago -
We live in a treat culture - and gen Z is splurging on snacks | Arwa Mahdawi
In times of hardship, people seek affordable luxuries like $19 smoothies. Erewhon, a trendy grocery store in LA, attracts influencers with pricey snacks. This "little treat culture" trend reflects the...
By The Guardian | 1 month ago
